Physician profile
Igor Elman
NPI 1285024026
$5,800.91
in general payments reported to CMS, 2019-2025
43 companies · $1,127 in 2025
The $1,127 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $434 · 2021: $585 · 2022: $1,031 · 2023: $1,365 · 2024: $1,047 · 2025: $1,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,540.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,540.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $790.89 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $788.15 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $476.29 | 2020-2025 | Tezspire, Repatha, Otezla |
| Astrazeneca Pharmaceuticals Lp | $465.48 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $399.27 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $352.06 | 2022-2025 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $322.38 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $284.33 | 2021-2025 | |
| Exact Sciences Corporation | $263.86 | 2023-2025 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $181.75 | 2022-2025 | Quviviq, Quviviq |
| Antares Pharma, INC. | $165.83 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $125.00 | 2024 | Terlivaz |
| Abbvie INC. | $122.71 | 2021-2023 | |
| Glaxosmithkline, LLC. | $102.40 | 2021-2024 | Nucala, Trelegy Ellipta |
| Biohaven Pharmaceuticals, INC. | $79.09 | 2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Elman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.